» Articles » PMID: 22971049

Proteomic Analysis of Chinese Hamster Ovary Cells

Abstract

To complement the recent genomic sequencing of Chinese hamster ovary (CHO) cells, proteomic analysis was performed on CHO cells including the cellular proteome, secretome, and glycoproteome using tandem mass spectrometry (MS/MS) of multiple fractions obtained from gel electrophoresis, multidimensional liquid chromatography, and solid phase extraction of glycopeptides (SPEG). From the 120 different mass spectrometry analyses generating 682,097 MS/MS spectra, 93,548 unique peptide sequences were identified with at most 0.02 false discovery rate (FDR). A total of 6164 grouped proteins were identified from both glycoproteome and proteome analysis, representing an 8-fold increase in the number of proteins currently identified in the CHO proteome. Furthermore, this is the first proteomic study done using the CHO genome exclusively, which provides for more accurate identification of proteins. From this analysis, the CHO codon frequency was determined and found to be distinct from humans, which will facilitate expression of human proteins in CHO cells. Analysis of the combined proteomic and mRNA data sets indicated the enrichment of a number of pathways including protein processing and apoptosis but depletion of proteins involved in steroid hormone and glycosphingolipid metabolism. Five-hundred four of the detected proteins included N-acetylation modifications, and 1292 different proteins were observed to be N-glycosylated. This first large-scale proteomic analysis will enhance the knowledge base about CHO capabilities for recombinant expression and provide information useful in cell engineering efforts aimed at modifying CHO cellular functions.

Citing Articles

Systems Biology of Recombinant 2G12 and 353/11 mAb Production in CHO-K1 Cell Lines at Phosphoproteome Level.

Sulaj E, Sandell F, Schwaigerlehner L, Marzban G, Dohm J, Kunert R Proteomes. 2025; 13(1).

PMID: 39982319 PMC: 11843875. DOI: 10.3390/proteomes13010009.


The 'Omics Revolution in CHO Biology: Roadmap to Improved CHO Productivity.

Dahodwala H, Sharfstein S Methods Mol Biol. 2024; 2853:119-137.

PMID: 39460918 DOI: 10.1007/978-1-0716-4104-0_9.


GenRCA: a user-friendly rare codon analysis tool for comprehensive evaluation of codon usage preferences based on coding sequences in genomes.

Fan K, Li Y, Chen Z, Fan L BMC Bioinformatics. 2024; 25(1):309.

PMID: 39333857 PMC: 11438159. DOI: 10.1186/s12859-024-05934-z.


From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies.

Majumdar S, Desai R, Hans A, Dandekar P, Jain R Mol Biotechnol. 2024; 67(2):369-392.

PMID: 38363529 DOI: 10.1007/s12033-024-01060-6.


Challenges and solutions for the downstream purification of therapeutic proteins.

Tang S, Tao J, Li Y Antib Ther. 2024; 7(1):1-12.

PMID: 38235378 PMC: 10791043. DOI: 10.1093/abt/tbad028.


References
1.
Dasari S, Chambers M, Slebos R, Zimmerman L, Ham A, Tabb D . TagRecon: high-throughput mutation identification through sequence tagging. J Proteome Res. 2010; 9(4):1716-26. PMC: 2859315. DOI: 10.1021/pr900850m. View

2.
Wei Y, Naderi S, Meshram M, Budman H, Scharer J, Ingalls B . Proteomics analysis of chinese hamster ovary cells undergoing apoptosis during prolonged cultivation. Cytotechnology. 2011; 63(6):663-77. PMC: 3217071. DOI: 10.1007/s10616-011-9385-2. View

3.
Liu H, Sadygov R, Yates 3rd J . A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004; 76(14):4193-201. DOI: 10.1021/ac0498563. View

4.
Walsh G . Biopharmaceutical benchmarks 2010. Nat Biotechnol. 2010; 28(9):917-24. DOI: 10.1038/nbt0910-917. View

5.
Lavner Y, Kotlar D . Codon bias as a factor in regulating expression via translation rate in the human genome. Gene. 2005; 345(1):127-38. DOI: 10.1016/j.gene.2004.11.035. View